Mr. Vipal Pratin Durkal, MD

Media Releases

Recognized as Texas Top Doctor 2024 for Excellence in Medicine

A dedicated hematologist-oncologist, Dr. Durkal is affiliated with Texas Oncology-Houston Medical Center.

Academically, he completed his fellowship in Hematology and Medical Oncology at the University of California Los Angeles Medical Center, where he honed his skills in diagnosing and treating various blood disorders and cancers. Before this, he completed his residency in Internal Medicine at the Medical College of Wisconsin, gaining essential experience in comprehensive patient management. He earned his medical degree from The University of Texas Health Science Center at Houston, solidifying his foundation in medical education and practice.

In addition to his clinical expertise, Dr. Durkal has a robust background in clinical research, particularly in novel imaging techniques that enhance cancer therapy. His innovative approach and dedication to advancing treatment options enable him to provide cutting-edge care to his patients. He is passionate about improving patient outcomes and is actively involved in research initiatives that aim to refine cancer treatment methodologies.

An authority in his field, Dr. Durkal has been recognized as one of the prestigious Texas Top Doctors for 2024. This accolade highlights his commitment to excellence in patient care and his significant contributions to the field of oncology.

On a more personal note, he enjoys running, cooking, and engaging in community service, demonstrating his commitment to both health and social responsibility. He values quality time spent with his family and maintains a keen interest in health policy and medical history, continually seeking to expand his knowledge and understanding of the medical field.

Fluent in English, Gujarati, and Spanish, Dr. Durkal effectively communicates with a diverse patient population, ensuring that language barriers do not impede the delivery of high-quality healthcare. His ability to connect with patients on a personal level fosters trust and enhances the overall patient experience.

Recommended Articles

• Little Boy Tugs at Heartstrings of Entire Community: Be the Match!

  Danny Feltwell, a young six-year-old boy, was diagnosed with T-cell lymphoblastic lymphoma when he was just two years old. After undergoing countless procedures and just four months from being considered fully cured, Danny relapsed and had to be re-hospitalized. The doctors found that a large tumor...

• Touchdown For Lymphoma: Two Teams Put Rivalry Aside For a Cause

  Everyone knows that some rivalries can get pretty heated - especially when sports are involved. However, two football teams recognize that there is something more important - supporting a girl with Hodgkin's lymphoma. Although she was a cheerleader for the football team, they are now turning the...

• How Dogs Are Helping with Lymphoma Research

  According to the Cornell Chronicle (CC), Cornell and Tufts University have received a huge grant for the study of human lymphoma, using a humane approach to test on dogs.The dogs in the study will already have lymphoma and it’s hoped they’ll be cured in the process of this research study.There...

• Lymphoma: The Importance of a Support System & Communication

  Regardless of what’s being said, communication is something that many people struggle with in their personal relationships. Communication requires self-awareness, listening skills, and the ability to empathize and convey thoughts and feelings accurately. When people are diagnosed with chronic...

• What are the Stages of Multiple Myeloma?

  This is the uncommon type of cancer that forms in plasma cells. A type of white blood cells found in the body, plasma cells, identify and battle germs and infections that attack the body.In multiple myeloma patients, the healthy plasma cells are overtaken by cancer cells. This reduces the number of...

• Genetic Advancements in Lymphoma Treatment

  Cancers are a huge focus for research. Millions of dollars every year are funneled into funding research that could improve treatment methods or find cures for cancer, including blood cancers. Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin’s lymphoma (NHL) accounting...